Kenji Sanada

1.2k total citations
28 papers, 821 citations indexed

About

Kenji Sanada is a scholar working on Biological Psychiatry, Molecular Biology and Physiology. According to data from OpenAlex, Kenji Sanada has authored 28 papers receiving a total of 821 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Biological Psychiatry, 8 papers in Molecular Biology and 8 papers in Physiology. Recurrent topics in Kenji Sanada's work include Tryptophan and brain disorders (10 papers), Gut microbiota and health (8 papers) and Diet and metabolism studies (7 papers). Kenji Sanada is often cited by papers focused on Tryptophan and brain disorders (10 papers), Gut microbiota and health (8 papers) and Diet and metabolism studies (7 papers). Kenji Sanada collaborates with scholars based in Japan, Spain and Brazil. Kenji Sanada's co-authors include Montserrat Salas Valero, Taishiro Kishimoto, Shunya Kurokawa, Masaru Mimura, Akira Iwanami, Daisuke Ikuse, Alberto Barceló‐Soler, Akihito Hirata, Akira Yoshizawa and Marcelo Demarzo and has published in prestigious journals such as Nature Immunology, PLoS ONE and Biological Psychiatry.

In The Last Decade

Kenji Sanada

26 papers receiving 813 citations

Peers

Kenji Sanada
Kenji Sanada
Citations per year, relative to Kenji Sanada Kenji Sanada (= 1×) peers Montserrat Salas Valero

Countries citing papers authored by Kenji Sanada

Since Specialization
Citations

This map shows the geographic impact of Kenji Sanada's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kenji Sanada with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kenji Sanada more than expected).

Fields of papers citing papers by Kenji Sanada

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kenji Sanada. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kenji Sanada. The network helps show where Kenji Sanada may publish in the future.

Co-authorship network of co-authors of Kenji Sanada

This figure shows the co-authorship network connecting the top 25 collaborators of Kenji Sanada. A scholar is included among the top collaborators of Kenji Sanada based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kenji Sanada. Kenji Sanada is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Tomioka, Hiroi, et al.. (2024). Neutrophil-Lymphocyte Ratio in Patients With Acute Schizophrenia. Cureus. 5 indexed citations
2.
Matsuzaki, Juntaro, Shunya Kurokawa, Akihiro Takamiya, et al.. (2024). Intestinal metabolites predict treatment resistance of patients with depression and anxiety. Gut Pathogens. 16(1). 8–8. 6 indexed citations
4.
Zhu, Xiaolei, Shinji Sakamoto, Chiharu Ishii, et al.. (2023). Dectin-1 signaling on colonic γδ T cells promotes psychosocial stress responses. Nature Immunology. 24(4). 625–636. 58 indexed citations
5.
Sanada, Kenji, Shunya Kurokawa, Chiharu Ishii, et al.. (2023). The relationship between sleep, gut microbiota, and metabolome in patients with depression and anxiety: A secondary analysis of the observational study. PLoS ONE. 18(12). e0296047–e0296047. 9 indexed citations
6.
Tomioka, Hiroi, et al.. (2023). Efficacy and safety of lemborexant as an alternative drug for patients with insomnia taking gamma‐aminobutyric acid–benzodiazepine receptor agonists or suvorexant. Human Psychopharmacology Clinical and Experimental. 38(3). e2868–e2868. 6 indexed citations
7.
Sanada, Kenji, Shunya Kurokawa, Chiharu Ishii, et al.. (2022). The Potential Impact of Age on Gut Microbiota in Patients with Major Depressive Disorder: A Secondary Analysis of the Prospective Observational Study. Journal of Personalized Medicine. 12(11). 1827–1827. 7 indexed citations
8.
Kurokawa, Shunya, Akihiro Takamiya, Chiharu Ishii, et al.. (2021). Fecal Microbial and Metabolomic Change during treatment course for depression: An Observational Study. Journal of Psychiatric Research. 140. 45–52. 11 indexed citations
9.
Kurokawa, Shunya, et al.. (2021). Gastrointestinal symptoms and sensory abnormalities associated with behavioral problems in children with neurodevelopmental disorders. Autism Research. 14(9). 1996–2001. 9 indexed citations
10.
Sanada, Kenji, Shinichiro Nakajima, Shunya Kurokawa, et al.. (2020). Gut microbiota and major depressive disorder: A systematic review and meta-analysis. Journal of Affective Disorders. 266. 1–13. 271 indexed citations
11.
Sanada, Kenji, Jesús Montero‐Marín, Alberto Barceló‐Soler, et al.. (2020). Effects of Mindfulness-Based Interventions on Biomarkers and Low-Grade Inflammation in Patients with Psychiatric Disorders: A Meta-Analytic Review. International Journal of Molecular Sciences. 21(7). 2484–2484. 60 indexed citations
12.
Miwa, Yusuke, et al.. (2018). A study on characteristics of rheumatoid arthritis patients achieving remission in depression with 6 months of bDMARDs treatment. European Journal of Rheumatology. 5(2). 4 indexed citations
13.
Sanada, Kenji, Sonia Ruiz de Azúa, Shinichiro Nakajima, et al.. (2018). Correlates of neurocognitive functions in individuals at ultra-high risk for psychosis - A 6-month follow-up study. Psychiatry Research. 268. 1–7. 7 indexed citations
14.
Sanada, Kenji, Montserrat Salas Valero, María Cruz Pérez-Yus, et al.. (2017). Effects of mindfulness-based interventions on biomarkers in healthy and cancer populations: a systematic review. BMC Complementary and Alternative Medicine. 17(1). 125–125. 44 indexed citations
15.
Miwa, Yusuke, Nobuyuki Yajima, Takeo Isozaki, et al.. (2017). SAT0085 A study on characteristics of rheumatoid arthritis patients achieving depression remission with 6 months of biologic agent treatment. Annals of the Rheumatic Diseases. 76. 800–801. 1 indexed citations
16.
Miwa, Yusuke, Ryo Takahashi, Nao Oguro, et al.. (2017). Clinical Characteristics of Rheumatoid Arthritis Patients Achieving Functional Remission with Six Months of Biological DMARDs Treatment. Internal Medicine. 56(8). 903–906. 12 indexed citations
17.
Miwa, Yusuke, et al.. (2017). The Relationship between the Serum Oxytocin Levels, Disease Activity, the ADLs and the QOL in Patients with Rheumatoid Arthritis. Internal Medicine. 56(23). 3167–3172. 2 indexed citations
18.
Sanada, Kenji, Jesús Montero‐Marín, Montserrat Salas Valero, et al.. (2016). Effects of Mindfulness-Based Interventions on Salivary Cortisol in Healthy Adults: A Meta-Analytical Review. Frontiers in Physiology. 7. 471–471. 84 indexed citations
19.
Martínez‐Cengotitabengoa, Mónica, et al.. (2016). Peripheral Inflammatory Parameters in Late-Life Depression: A Systematic Review. International Journal of Molecular Sciences. 17(12). 2022–2022. 68 indexed citations
20.
Sanada, Kenji, Montserrat Salas Valero, María Cruz Pérez-Yus, et al.. (2015). Effects of non-pharmacological interventions on inflammatory biomarker expression in patients with fibromyalgia: a systematic review. Arthritis Research & Therapy. 17(1). 272–272. 34 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026